Cogent Biosciences, Inc. COGT Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Cogent Biosciences, Inc. (COGT) reported comprehensive income (loss), net of tax, attributable to parent of -$98.12M in Q1 2026.
- How has Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 35.8% year-over-year, from -$72.27M to -$98.12M.
- What is the long-term trend for Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 46.1% compound annual growth rate (CAGR), from -$72.24M to -$329.03M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric combines net income with other comprehensive income to provide a holistic view of the total change in shareholder equity during the period. It accounts for all financial activities, including operational results and unrealized market fluctuations. This figure is essential for assessing the total economic impact of the company's activities on its capital base.